Green Cross Labcell acquires U.S. patent of cell therapy mass production
Green Cross Labcell acquired a U.S. patent about mass production of cell therapy.
Green Cross Labcell(CEO Dae-Woo Park) announced on the 23rd that the company acquired a patent about culture method of natural killer cells from the United States Patent and Trademark Office(USPTO).
Green Cross La...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
